PIOGLITAZONE-AS pioglitazone (as hydrochloride) 15mg tablet blister pack

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: Department of Health (Therapeutic Goods Administration)

Δραστική ουσία:

pioglitazone hydrochloride, Quantity: 16.536 mg (Equivalent: pioglitazone, Qty 15 mg)

Διαθέσιμο από:

Medis Pharma Pty Ltd

INN (Διεθνής Όνομα):

Pioglitazone hydrochloride

Φαρμακοτεχνική μορφή:

Tablet

Σύνθεση:

Excipient Ingredients: lactose monohydrate; carmellose calcium; hyprolose; magnesium stearate

Οδός χορήγησης:

Oral

Μονάδες σε πακέτο:

7 tablets, 50 tablets, 28 tablets, 98 tablets

Τρόπος διάθεσης:

(S4) Prescription Only Medicine

Θεραπευτικές ενδείξεις:

Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea

Περίληψη προϊόντος:

Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with '140' on one side and '15' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Καθεστώς αδειοδότησης:

Licence status A

Ημερομηνία της άδειας:

2011-10-26